Propanc Biopharma,'s market value is the price at which a share of Propanc Biopharma, trades on a public exchange. It measures the collective expectations of Propanc Biopharma Common investors about its performance. Propanc Biopharma, is trading at 0.27 as of the 23rd of January 2026, a 10 percent decrease since the beginning of the trading day. The stock's open price was 0.3. With this module, you can estimate the performance of a buy and hold strategy of Propanc Biopharma Common and determine expected loss or profit from investing in Propanc Biopharma, over a given investment horizon. Check out Propanc Biopharma, Correlation, Propanc Biopharma, Volatility and Propanc Biopharma, Alpha and Beta module to complement your research on Propanc Biopharma,.
Please note, there is a significant difference between Propanc Biopharma,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Propanc Biopharma, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Propanc Biopharma,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Propanc Biopharma, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Propanc Biopharma,'s pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Propanc Biopharma,.
0.00
10/25/2025
No Change 0.00
0.0
In 3 months and 1 day
01/23/2026
0.00
If you would invest 0.00 in Propanc Biopharma, on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Propanc Biopharma Common or generate 0.0% return on investment in Propanc Biopharma, over 90 days. Propanc Biopharma, is related to or competes with Telescope Innovations, ImmunoCellular Therapeutics, Cell Source, and Hookipa Pharma. Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, ... More
Propanc Biopharma, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Propanc Biopharma,'s pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Propanc Biopharma Common upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Propanc Biopharma,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Propanc Biopharma,'s standard deviation. In reality, there are many statistical measures that can use Propanc Biopharma, historical prices to predict the future Propanc Biopharma,'s volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Propanc Biopharma,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Propanc Biopharma Common maintains Sharpe Ratio (i.e., Efficiency) of -0.48, which implies the firm had a -0.48 % return per unit of risk over the last 3 months. Propanc Biopharma Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Propanc Biopharma,'s Risk Adjusted Performance of (0.32), coefficient of variation of (224.25), and Variance of 31.02 to confirm the risk estimate we provide. The company holds a Beta of 0.47, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Propanc Biopharma,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Propanc Biopharma, is expected to be smaller as well. At this point, Propanc Biopharma Common has a negative expected return of -2.64%. Please make sure to check Propanc Biopharma,'s potential upside and the relationship between the accumulation distribution and period momentum indicator , to decide if Propanc Biopharma Common performance from the past will be repeated at some point in the near future.
Auto-correlation
0.76
Good predictability
Propanc Biopharma Common has good predictability. Overlapping area represents the amount of predictability between Propanc Biopharma, time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Propanc Biopharma Common price movement. The serial correlation of 0.76 indicates that around 76.0% of current Propanc Biopharma, price fluctuation can be explain by its past prices.
Correlation Coefficient
0.76
Spearman Rank Test
0.65
Residual Average
0.0
Price Variance
0.03
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Propanc Pink Sheet
Propanc Biopharma, financial ratios help investors to determine whether Propanc Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Propanc with respect to the benefits of owning Propanc Biopharma, security.